Volume Replacement

1. Front Matter

   Pages I-X

   PDF

2. Albumin: To Use or Not to Use? Contemporary Alternatives?

   • H. Haljamäe

   Pages 1-22

3. Use of Gelatins as Volume Expanders in Shock and Trauma

   • J. D. Edwards

   Pages 23-46

4. Which Hydroxyethyl Starch for Which Indication?

   • G. Audibert, M. C. Laxenaire

   Pages 47-55

5. Volume Replacement Therapy with Dextrans: Are Dextrans Still Useful in Volume Replacement?

   • H. Litvan, J. I. Casas, J. M. Villar-Landeira

   Pages 57-66

6. Volume Replacement in the Critically Ill

   • J. Boldt

   Pages 67-74

7. Bleeding Complications and Hydroxyethyl Starch: Strategies of Prevention

   • J. Treib, M. Stoll

   Pages 75-89

8. Volume Replacement in Burn Patients

   • D. Balogh

   Pages 91-97

9. Use of Plasma Substitutes During Cardiac Surgery: Focus on Priming Solutions

   • D. Himpe

   Pages 99-110

10. Colloid-Induced Renal Complications

    • J.-F. Baron

    Pages 111-120

11. New Therapeutic Concepts Using Artificial Oxygen Carriers

    • D. R. Spahn

    Pages 121-133

12. Back Matter

    Pages 135-145

    PDF

Because of their therapeutic safety, hydroxyethylstarch, gelatin and dextrans are among the most frequently used drugs in the world. Recent studies have shown that bleeding disorders, anaphylactic reactions and storage in the body depend decisively on the nature of the administered plasma substitute. Through interdisciplinary cooperation the "First European Volume Replacement Conference" has established indications for the use of individual plasma substitutes to improve the efficacy and therapeutic safety of volume replacement therapy.

• Blutersatzstoffe
• Trauma
• Volume Replacement
• aextrans
• complications
• gelatins
• oxygen carriers
• plasma
• plasma volume support
• shock
• surgery

• Anesthesie-Reanimation, Université Pierre et Marie Curie Paris VI, Paris, France

  Jean-Francois Baron

• Neurologische Klinik, Universitätskliniken des Saarlandes, Homburg/Saar, Germany

  Johannes Treib

Policies and ethics